Legend Biotech (LEGN) Shares Outstanding (Weighted Average) (2019 - 2025)

Legend Biotech has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $100.0 billion in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $100.0 billion; the trailing twelve-month figure through Dec 2025 stood at $100.0 billion (changed 0.0% YoY), and the FY2025 full-year result was $100.0 billion, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $100.0 billion, up from $37.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $100.0 billion in Q4 2024, with the low at $620.0 in Q2 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $10.1 billion across 5 years, with a median of $37.0 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) surged 277777677.78% — and 2025, when it slumped 100.0%.
• Legend Biotech's Shares Outstanding (Weighted Average) stood at $281.7 million in 2021, then rose by 12.91% to $318.1 million in 2022, then slumped by 99.99% to $36000.0 in 2023, then surged by 277777677.78% to $100.0 billion in 2024, then changed by 0.0% to $100.0 billion in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $100.0 billion (Q4 2025), $37.0 million (Q3 2025), and $620.0 (Q2 2025), per Business Quant data.